Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed Medication

BACKGROUND: Beta-blocker (BB) therapy after myocardial infarction (MI) reduces all-cause mortality. OBJECTIVE: The aim of this study was to investigate BB dosing patterns and compliance following MI. METHODS: Using medical patient files and nationwide databases, we identified 100 patients who were d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Susanne Bendesgaard, Nielsen, Jens Cosedis, Bøtker, Hans Erik, Goldberger, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042935/
https://www.ncbi.nlm.nih.gov/pubmed/27747827
http://dx.doi.org/10.1007/s40801-016-0079-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042935/
https://www.ncbi.nlm.nih.gov/pubmed/27747827
http://dx.doi.org/10.1007/s40801-016-0079-0

Ejemplares similares